SOFTMEDX (00648) Issues Approximately 16.3 Million Scheme Shares at 96% Discount

Stock News
03/10

SOFTMEDX (00648) announced that, due to a continued deterioration of its financial condition since trading was suspended, the company resolved in 2023 to proceed with a debt restructuring via a scheme. In December 2023, the scheme was registered with the Companies Registry and became effective. To fulfill the scheme's requirements, the company must issue 16,301,841 scheme shares to creditors at an issue price of HK$0.01 per share within six months from the resumption of trading. The issue price represents a 96% discount to the closing price of HK$0.28 per share as quoted on the Stock Exchange on the date of this announcement.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10